Clinical significance and functional role of adhesion G-protein-coupled receptors in human pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

Clinical significance and functional role of adhesion G-protein-coupled receptors in human pancreatic ductal adenocarcinoma

Published:2022-11-17 Issue:2 Volume:128 Page:321-330
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Nishiwada Satoshi,Shimura Tadanobu,Yamamura Kensuke,Nakagawa Kenji,Nagai Minako,Nakamura Kota,Terai Taichi,Yamada Suguru,Fujii Tsutomu,Kodera Yasuhiro,Sho Masayuki,Goel Ajay^ORCID

Funder

Foundation for the National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-022-02057-1.pdf

Reference58 articles.

1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71:7–33.

2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

3. Puleo F, Nicolle R, Blum Y, Cros J, Marisa L, Demetter P, et al. Stratification of pancreatic ductal adenocarcinomas based on tumor and microenvironment features. Gastroenterology. 2018;155:1999–2013.e1993.

4. Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369:1691–703.

5. Okada KI, Shimokawa T, Hirono S, Kawai M, Sho M, Satoi S, et al. Effect of neoadjuvant nab-paclitaxel plus gemcitabine therapy on overall survival in patients with borderline resectable pancreatic cancer: a prospective multicenter phase II trial (NAC-GA Trial). Oncology. 2017;93:343–6.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets for breast cancer;Breast Cancer Research and Treatment;2024-06-04

2. Intratumoral CD38+CD19+B cells associate with poor clinical outcomes and immunosuppression in patients with pancreatic ductal adenocarcinoma;eBioMedicine;2024-05